Literature DB >> 18486720

Nephrolithiasis.

Elaine M Worcester1, Fredric L Coe.   

Abstract

Kidney stones affect more than 5% of adults in the United States, and the prevalence is rising. The fundamental cause for all stones is supersaturation of urine with respect to the stone components; factors affecting solubility include urine volume, pH, and total solute excretion. Calcium stones are the most common in both adults and children and are associated with several metabolic disorders, the most common of which is idiopathic hypercalciuria. Therapy to prevent stones rests on lowering supersaturation, using both diet and medication. Effective treatment decreases stone recurrence and the need for procedures for stone removal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486720      PMCID: PMC2518455          DOI: 10.1016/j.pop.2008.01.005

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  70 in total

1.  Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.

Authors:  Kristin J Bergsland; Jennifer K Kelly; Brian J Coe; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2006-04-18

2.  Urinary metabolic evaluations in normal and stone forming children.

Authors:  William DeFoor; John Asplin; Elizabeth Jackson; Chad Jackson; Pramod Reddy; Curtis Sheldon; Michael Erhard; Eugene Minevich
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

3.  Renal function in patients with nephrolithiasis.

Authors:  Elaine M Worcester; Joan H Parks; Andrew P Evan; Fredric L Coe
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

Review 4.  Medical therapy to facilitate urinary stone passage: a meta-analysis.

Authors:  John M Hollingsworth; Mary A M Rogers; Samuel R Kaufman; Timothy J Bradford; Sanjay Saint; John T Wei; Brent K Hollenbeck
Journal:  Lancet       Date:  2006-09-30       Impact factor: 79.321

5.  Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis.

Authors:  Elaine M Worcester; Daniel L Gillen; Andrew P Evan; Joan H Parks; Katrina Wright; Linda Trumbore; Yasushi Nakagawa; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2007-01

6.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

Review 7.  Microorganisms and calcium oxalate stone disease.

Authors:  David S Goldfarb
Journal:  Nephron Physiol       Date:  2004

8.  Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones.

Authors:  Joan H Parks; Elaine M Worcester; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

9.  Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.

Authors:  Wesley O Ekeruo; Yeh Hong Tan; Matthew D Young; Philipp Dahm; Michaella E Maloney; Barbara J Mathias; David M Albala; Glenn M Preminger
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

10.  Familial idiopathic hypercalciuria.

Authors:  F L Coe; J H Parks; E S Moore
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

View more
  54 in total

1.  Motion artifacts in kidney stone imaging using single-source and dual-source dual-energy CT scanners: a phantom study.

Authors:  El-Sayed H Ibrahim; Joseph G Cernigliaro; Robert A Pooley; James C Williams; William E Haley
Journal:  Abdom Imaging       Date:  2015-10

2.  Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model.

Authors:  Isabel Garcia-Perez; Alma Villaseñor; Anisha Wijeyesekera; Joram M Posma; Zhirong Jiang; Jeremiah Stamler; Peter Aronson; Robert Unwin; Coral Barbas; Paul Elliott; Jeremy Nicholson; Elaine Holmes
Journal:  J Proteome Res       Date:  2012-08-28       Impact factor: 4.466

3.  The epithelial sodium/proton exchanger, NHE3, is necessary for renal and intestinal calcium (re)absorption.

Authors:  Wanling Pan; Jelena Borovac; Zachary Spicer; Joost G Hoenderop; René J Bindels; Gary E Shull; Michael R Doschak; Emmanuelle Cordat; R Todd Alexander
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

4.  Metabolomic and lipidomic characterization of Oxalobacter formigenes strains HC1 and OxWR by UHPLC-HRMS.

Authors:  Casey A Chamberlain; Marguerite Hatch; Timothy J Garrett
Journal:  Anal Bioanal Chem       Date:  2019-02-11       Impact factor: 4.142

Review 5.  Kidney stones: an update on current pharmacological management and future directions.

Authors:  Hongshi Xu; Anna L Zisman; Fredric L Coe; Elaine M Worcester
Journal:  Expert Opin Pharmacother       Date:  2013-03       Impact factor: 3.889

6.  A man with multiple abdominal calcifications.

Authors:  M Rohsila; D Nani; Y Siti Suhaila
Journal:  Malays Fam Physician       Date:  2012-04-30

7.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

8.  Some Work on the Diagnosis and Management of Kidney Stones with Ultrasound.

Authors:  Julianna C Simon; Adam D Maxwell; Michael R Bailey
Journal:  Acoust Today       Date:  2017

Review 9.  Herbal medicines in the management of urolithiasis: alternative or complementary?

Authors:  Veronika Butterweck; Saeed R Khan
Journal:  Planta Med       Date:  2009-05-14       Impact factor: 3.352

Review 10.  Randall's plaques, plugs and the clinical workup of the renal stone patient.

Authors:  Pietro Manuel Ferraro; Ferraro Pietro Manuel; Alessandro D'Addessi; D'Addessi Alessandro; Giovanni Gambaro; Gambaro Giovanni
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.